Journal of the Royal Society of Medicine

(The H4-Index of Journal of the Royal Society of Medicine is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-01-01 to 2024-01-01.)
Symptoms, complications and management of long COVID: a review428
Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide?201
Uncertainty and COVID-19: how are we to respond?154
The primary care response to COVID-19 in England's National Health Service97
COVID-19 vaccine hesitancy: the five Cs to tackle behavioural and sociodemographic factors77
Environmental impact of personal protective equipment distributed for use by health and social care services in England in the first six months of the COVID-19 pandemic76
Impact of COVID-19 on accident and emergency attendances and emergency and planned hospital admissions in Scotland: an interrupted time-series analysis74
Four months into the COVID-19 pandemic, Sweden’s prized herd immunity is nowhere in sight65
Ethnicity, household composition and COVID-19 mortality: a national linked data study59
Loneliness, social isolation, cardiovascular disease and mortality: a synthesis of the literature and conceptual framework56
Anger and confrontation during the COVID-19 pandemic: a national cross-sectional survey in the UK48
COVID-19 presents opportunities and threats to transport and health42
Plastics in healthcare: time for a re-evaluation41
Suicide reduction in Canada during the COVID-19 pandemic: lessons informing national prevention strategies for suicide reduction40
Clinical impact of multi-parameter continuous non-invasive monitoring in hospital wards: a systematic review and meta-analysis36
Health inequalities: the hidden cost of COVID-19 in NHS hospital trusts?36
COVID-19: the great unequaliser33
Developing a sustainable exit strategy for COVID-19: health, economic and public policy implications33
What do countries need to do to implement effective ‘find, test, trace, isolate and support’ systems?33
Vaccinating adolescents against SARS-CoV-2 in England: a risk–benefit analysis29
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study23
Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps23
Protecting older people from COVID-19: should the United Kingdom start at age 60?23